Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Eye & Contact Lens
|
August 31, 2011
Trichosporon asahii keratitis in a patient with a type I Boston keratoprosthesis and contact lens
Anne Keating, Roberto Pineda
Seminars in Ophthalmology
|
November 25, 2010
Corneal cross linking for keratoconus
Anne Keating, Roberto Pineda, Kathryn Colby
International Journal for Parasitology
|
July 16, 2002
Diplostomum spathaceum cercariae respond to a unique profile of cues during recognition of their fish host
Wilfried Haas, Petra Stiegeler, Anne Keating, et al.
Breast Cancer Research and Treatment
|
December 31, 2014
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer
Michael R Clemens, Oleg A Gladkov, Elaina Gartner, et al.
Leukemia & Lymphoma
|
February 10, 2016
A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma
Kyriakos P Papadopoulos, Javier Lopez-Jimenez, Scott E Smith, et al.
Cancer Medicine
|
December 24, 2014
A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma
Ragini Kudchadkar, Scott Ernst, Bartosz Chmielowski, et al.
Blood
|
January 17, 2013
Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia
Jing Chen, Cynthia A Pise-Masison, Joanna H Shih, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2016
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer
Al B Benson, Igor Kiss, John Bridgewater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2008
Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin
Anthony W Tolcher, Alain Mita, Lionel D Lewis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2017
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Helena A Yu, Alexander Spira, Leora Horn, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Eye & Contact Lens
|
August 31, 2011
Trichosporon asahii keratitis in a patient with a type I Boston keratoprosthesis and contact lens
Anne Keating, Roberto Pineda
Seminars in Ophthalmology
|
November 25, 2010
Corneal cross linking for keratoconus
Anne Keating, Roberto Pineda, Kathryn Colby
International Journal for Parasitology
|
July 16, 2002
Diplostomum spathaceum cercariae respond to a unique profile of cues during recognition of their fish host
Wilfried Haas, Petra Stiegeler, Anne Keating, et al.
Breast Cancer Research and Treatment
|
December 31, 2014
Phase II, multicenter, open-label, randomized study of YM155 plus docetaxel as first-line treatment in patients with HER2-negative metastatic breast cancer
Michael R Clemens, Oleg A Gladkov, Elaina Gartner, et al.
Leukemia & Lymphoma
|
February 10, 2016
A multicenter phase II study of sepantronium bromide (YM155) plus rituximab in patients with relapsed aggressive B-cell Non-Hodgkin lymphoma
Kyriakos P Papadopoulos, Javier Lopez-Jimenez, Scott E Smith, et al.
Cancer Medicine
|
December 24, 2014
A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma
Ragini Kudchadkar, Scott Ernst, Bartosz Chmielowski, et al.
Blood
|
January 17, 2013
Markedly additive antitumor activity with the combination of a selective survivin suppressant YM155 and alemtuzumab in adult T-cell leukemia
Jing Chen, Cynthia A Pise-Masison, Joanna H Shih, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2016
BATON-CRC: A Phase II Randomized Trial Comparing Tivozanib Plus mFOLFOX6 with Bevacizumab Plus mFOLFOX6 in Stage IV Metastatic Colorectal Cancer
Al B Benson, Igor Kiss, John Bridgewater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 2008
Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin
Anthony W Tolcher, Alain Mita, Lionel D Lewis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2017
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Helena A Yu, Alexander Spira, Leora Horn, et al.
Page
of 1